Management of Chemotherapy-Induced Nausea and Vomiting

New Agents and New Uses of Current Agents

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Oncology
Cover of the book Management of Chemotherapy-Induced Nausea and Vomiting by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319270166
Publisher: Springer International Publishing Publication: January 25, 2016
Imprint: Adis Language: English
Author:
ISBN: 9783319270166
Publisher: Springer International Publishing
Publication: January 25, 2016
Imprint: Adis
Language: English

This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings.

CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients’ perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. 

This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings.

CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients’ perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. 

This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.

More books from Springer International Publishing

Cover of the book Reconstruction, Identification and Implementation Methods for Spiking Neural Circuits by
Cover of the book Recent Developments in Braiding and Narrow Weaving by
Cover of the book Asymmetric Cell Division in Development, Differentiation and Cancer by
Cover of the book Algebraic Number Theory by
Cover of the book Formality Theory by
Cover of the book Congenital Müllerian Anomalies by
Cover of the book Stability and Performance of Control Systems with Actuator Saturation by
Cover of the book Concepts and Formulations for Spatial Multibody Dynamics by
Cover of the book A History of Palliative Care, 1500-1970 by
Cover of the book Sustainable Vernacular Architecture by
Cover of the book The Union of Chemistry and Physics by
Cover of the book System Analysis and Modeling. Technology-Specific Aspects of Models by
Cover of the book Distributed Applications and Interoperable Systems by
Cover of the book The Worlds of Positivism by
Cover of the book A Starter on Support-Bargaining and Money-Bargaining in Twenty-Eight Digestible Bites by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy